AKT1 and metabolic dysfunction-associated steatotic liver disease: The insulin resistance pathway, PI3K-Akt signaling pathway, and nonalcoholic fatty liver disease are characterized by relatively high −log10(P-value) in Figure 2 and also by the relative high degree in the network, which may provide more possibility for the search of potential targets within the pathway.